Results 41 to 50 of about 104,265 (300)
Functional peptide-loaded gelatin nanoparticles as eyedrops for cornea neovascularization treatment
, 2023 [[abstract]]Background: Corneal neovascularization (NV) is a process of abnormal vessel growth into the transparent cornea from the limbus and can disturb the light passing through the cornea, resulting in vision loss or even blindness.
Chu, YC;Fang, HW;Wu, YY;Tang, YJ;Hsieh, EH;She, YZ;Chang, CY;Lin, IC;Chen, YJ;Liu, GS;Tseng, CL +11 more
core +1 more source
Immunomodulatory Nanomedicine [PDF]
Macromolecular Bioscience, 2017 AbstractImmunity has a major impact on inflammatory diseases and cancer, and biologics targeting immune cells and their factors reach a quarter trillion of market volume by this year. Adaptive leukocytes have recently been engaged in cancer immunotherapy, whereas modulation of the innate immune cells, specifically macrophages, is expected as next ...
openaire +2 more sources
The nanomedicine landscape of South Africa
Nanotechnology Reviews, 2017 Nanomedicine is one of the most exciting applications of nanotechnology and promises to address several of mankind’s healthcare needs. South Africa is one of the countries engaged in nanomedicine research and product development on the African continent.
Dube Admire, Ebrahim Naushaad
doaj +1 more source
Editorial on Advanced Nanomedicine
, 2018 In advanced nanomedicine not only construction and repairing of human biological systems; but also monitoring and controlling can be implemented using nanostructures and nanobots at molecular level.
Mitra, Manu
core +1 more source
Introduction to Nanomedicine [PDF]
Molecules, 2015 Although mentions of nanoparticles in relation to biomedicine appeared in the late 1970s and are now the subject of over 10,000 publications per year, the term “Nanomedicine” only appeared at the turn of this century, and less than 30 papers including this term were published up to 2005. [...]
openaire +3 more sources
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
Molecular Oncology, EarlyView.LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir +9 more
wiley +1 more source
RNA BiologyThe current letter to the editor describes the presence of RNA byproducts in small-scale in vitro transcription (IVT) reactions as evaluated by capillary gel electrophoresis, asymmetric flow field flow fractionation, immunoblotting, cell-free translation
Combes Francis +6 more
doaj +1 more source
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control [PDF]
, 2015 The current enhanced permeability and retention (EPR)-based approved nanomedicines have had little impact in terms of prolongation of overall survival in patients with cancer. For example, the two Phase III trials comparing Doxil®, the first nanomedicine
Liu, Ren Shyan +21 more
core +1 more source
FEBS Open Bio, EarlyView.UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová +2 more
wiley +1 more source
FEBS Open Bio, EarlyView.This minireview explores fluorination as a key strategy to optimize therapeutic molecules and nanocarriers. By incorporating different fluorinated motifs—from single atoms to linear and branched chains—drug delivery, cellular uptake, and colloidal stability can be improved and fine‐tuned.
Martina Beccalli +2 more
wiley +1 more source